|Global Clinical Session|
Featured Session: Adapting Strategic Partnerships to the Needs of Emerging Markets
Featured Speakers: Octavio Costa, MD, Executive Director, EM Clinical Development Operations, Merck & Co., Inc.
Christopher Erickson, Vice President, Strategic Account Leader, PAREXEL International Corporation
About the session: Over the last several years clinical development has seen the rise in strategic partnerships between sponsors and their suppliers as well as the drive to expand research in emerging markets. These two trends have coalesced and created a robust set of lessons learned on what sponsors and CROs can do to maximize their relationships in emerging regions. Several critical areas have been identified to the success of a partnership centered on emerging regions. This session explores best practices through the use of various case studies.
- • Understand the key differences of conducting clinical trials in emerging markets
- • Techniques to maximize strategic partnerships in emerging regions including identifying and prioritizing the partnership infrastructure and adapting key areas of governance